Emerging data on psychedelics demonstrate efficacy in preventing cluster headaches.
Jillian Hernandez, MS, BS, BA
Advertisement
Articles by Jillian Hernandez, MS, BS, BA
Emerging evidence supports the use of psilocybin in palliative care, yet Schedule I status uniquely limits access outside of clinical trials in the US.
Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.
Advertisement
Latest Updated Articles
Pathways to Psilocybin in Palliative CareMay 14th 2026
Psychedelics in Cluster Headaches Break the Pain CycleJuly 14th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
2
FDA Grants Fast Track Designation to CK0803 for Amyotrophic Lateral Sclerosis
3
Yeast-Based Universal Flu Vaccine Fully Protects Mice Against 3 Influenza Strains
4
Pharmacists' Expanding Role in MASLD Screening and Care
5